Sami Oikarinen

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 14

Top Topics

Newly Diagnosed

Peripheral Blood

Top Venues

JMIR public health and surveillance

Science advances

This page only lists publications with an associated author ORCID identifier.

Publications

Heikki Hyöty, Susanna Kääriäinen, Jutta E Laiho, Gail M Comer, Wei Tian, Taina Härkönen, Jussi P Lehtonen, Sami Oikarinen, Leena Puustinen, Michele Snyder, Francisco León, Mika Scheinin, Olli H Laitinen, Miguel Sanjuan
Safety, tolerability and immunogenicity of PRV-101, a multivalent vaccine targeting coxsackie B viruses (CVBs) associated with type 1 diabetes: a double-blind randomised placebo-controlled Phase I trial. Diabetologia 67 (5) (2024)
Annika Länsivaara, Kirsi-Maarit Lehto, Rafiqul Hyder, Erja Sinikka Janhonen, Anssi Lipponen, Annamari Heikinheimo, Tarja Pitkänen, Sami Oikarinen, null null
Comparison of Different Reverse Transcriptase-Polymerase Chain Reaction-Based Methods for Wastewater Surveillance of SARS-CoV-2: Exploratory Study. JMIR public health and surveillance 10 (2024)
Annika Länsivaara, Kirsi-Maarit Lehto, Rafiqul Hyder, Erja Sinikka Janhonen, Anssi Lipponen, Annamari Heikinheimo, Tarja Pitkänen, Sami Oikarinen, null null
Comparison of Different Reverse Transcriptase-Polymerase Chain Reaction-Based Methods for Wastewater Surveillance of SARS-CoV-2: Exploratory Study. JMIR public health and surveillance 10 (2024)
Heikki Hyöty, Susanna Kääriäinen, Jutta E Laiho, Gail M Comer, Wei Tian, Taina Härkönen, Jussi P Lehtonen, Sami Oikarinen, Leena Puustinen, Michele Snyder, Francisco León, Mika Scheinin, Olli H Laitinen, Miguel Sanjuan
Safety, tolerability and immunogenicity of PRV-101, a multivalent vaccine targeting coxsackie B viruses (CVBs) associated with type 1 diabetes: a double-blind randomised placebo-controlled Phase I trial. Diabetologia 67 (5) (2024)
Heikki Hyöty, Susanna Kääriäinen, Jutta E Laiho, Gail M Comer, Wei Tian, Taina Härkönen, Jussi P Lehtonen, Sami Oikarinen, Leena Puustinen, Michele Snyder, Francisco León, Mika Scheinin, Olli H Laitinen, Miguel Sanjuan
Safety, tolerability and immunogenicity of PRV-101, a multivalent vaccine targeting coxsackie B viruses (CVBs) associated with type 1 diabetes: a double-blind randomised placebo-controlled Phase I trial. Diabetologia 67 (5) (2024)
Heikki Hyöty, Susanna Kääriäinen, Jutta E Laiho, Gail M Comer, Wei Tian, Taina Härkönen, Jussi P Lehtonen, Sami Oikarinen, Leena Puustinen, Michele Snyder, Francisco León, Mika Scheinin, Olli H Laitinen, Miguel Sanjuan
Safety, tolerability and immunogenicity of PRV-101, a multivalent vaccine targeting coxsackie B viruses (CVBs) associated with type 1 diabetes: a double-blind randomised placebo-controlled Phase I trial. Diabetologia 67 (5) (2024)
Annika Länsivaara, Kirsi-Maarit Lehto, Rafiqul Hyder, Erja Sinikka Janhonen, Anssi Lipponen, Annamari Heikinheimo, Tarja Pitkänen, Sami Oikarinen, null null
Comparison of Different Reverse Transcriptase-Polymerase Chain Reaction-Based Methods for Wastewater Surveillance of SARS-CoV-2: Exploratory Study. JMIR public health and surveillance 10 (2024)
Heikki Hyöty, Susanna Kääriäinen, Jutta E Laiho, Gail M Comer, Wei Tian, Taina Härkönen, Jussi P Lehtonen, Sami Oikarinen, Leena Puustinen, Michele Snyder, Francisco León, Mika Scheinin, Olli H Laitinen, Miguel Sanjuan
Safety, tolerability and immunogenicity of PRV-101, a multivalent vaccine targeting coxsackie B viruses (CVBs) associated with type 1 diabetes: a double-blind randomised placebo-controlled Phase I trial. Diabetologia 67 (5) (2024)
Heikki Hyöty, Susanna Kääriäinen, Jutta E Laiho, Gail M Comer, Wei Tian, Taina Härkönen, Jussi P Lehtonen, Sami Oikarinen, Leena Puustinen, Michele Snyder, Francisco León, Mika Scheinin, Olli H Laitinen, Miguel Sanjuan
Safety, tolerability and immunogenicity of PRV-101, a multivalent vaccine targeting coxsackie B viruses (CVBs) associated with type 1 diabetes: a double-blind randomised placebo-controlled Phase I trial. Diabetologia (2024)
Amir-Babak Sioofy-Khojine, Sarah J Richardson, Jonathan M Locke, Sami Oikarinen, Noora Nurminen, Antti-Pekka Laine, Kate Downes, Johanna Lempainen, John A Todd, Riitta Veijola, Jorma Ilonen, Olli H Laitinen, Noel G Morgan, Heikki Hyöty, Mark Peakman, Martin Eichmann
Detection of enterovirus RNA in peripheral blood mononuclear cells correlates with the presence of the predisposing allele of the type 1 diabetes risk gene IFIH1 and with disease stage. Diabetologia 65 (10) (2022)
Sami Oikarinen, Lars Krogvold, Bjørn Edwin, Trond Buanes, Olle Korsgren, Jutta E Laiho, Maarit Oikarinen, Johnny Ludvigsson, Oskar Skog, Mahesh Anagandula, Gun Frisk, Heikki Hyöty, Knut Dahl-Jørgensen
Characterisation of enterovirus RNA detected in the pancreas and other specimens of live patients with newly diagnosed type 1 diabetes in the DiViD study. Diabetologia 64 (11) (2021)
Anni Honkimaa, Bryn Kimura, Amir-Babak Sioofy-Khojine, Jake Lin, Jutta Laiho, Sami Oikarinen, Heikki Hyöty
Genetic Adaptation of Coxsackievirus B1 during Persistent Infection in Pancreatic Cells. Microorganisms 8 (11) (2020)
Maarit Oikarinen, Lori Bertolet, Antonio Toniolo, Sami Oikarinen, Jutta E Laiho, Alberto Pugliese, Richard E Lloyd, Heikki Hyöty, null The nPOD-V Study Group
Differential Detection of Encapsidated versus Unencapsidated Enterovirus RNA in Samples Containing Pancreatic Enzymes-Relevance for Diabetes Studies. Viruses 12 (7) (2020)
Marja I Roslund, Riikka Puhakka, Mira Grönroos, Noora Nurminen, Sami Oikarinen, Ahmad M Gazali, Ondrej Cinek, Lenka Kramná, Nathan Siter, Heli K Vari, Laura Soininen, Anirudra Parajuli, Juho Rajaniemi, Tuure Kinnunen, Johanna Lempainen, Heikki Hyöty, Aki Sinkkonen, null null
Biodiversity intervention enhances immune regulation and health-associated commensal microbiota among daycare children. Science advances 6 (42) (2020)